Deleted No
Hibernated No
Last Checked Dec. 3, 2022

Created

Fri Dec 02 01:02:58 +0000 2022

Likes

14

Retweets

8

Source

Twitter Web App

View Raw Data

JSON Data

View on Twitter

Likely Available
Profile Image

NEWS MAKER @NEWS_MAKER

A key monoclonal antibody used to treat people with weak immune systems who catch Covid is no longer authorized for use in the U.S. because it is not effective against emerging omicron subvariants. https://t.co/Uu1UezAk1b — PolitiTweet.org

Posted Dec. 2, 2022